Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia

ABSTRACT:The emergence of the Omicron variant has generated concerns about the efficacy of COVID-19 vaccines. We evaluated the serum neutralizing activity of antibodies against the Omicron (lineage BA.1.1) by plaque reduction neutralizing test, as well as its correlation with age and gender, in a Co...

Full description

Autores:

Zapata Cardona, María Isabel
Flórez Álvarez, Lizdany
Lopera Restrepo, Tulio José
Medina Chvatal, Mateo
Zapata Builes, Wildeman
Díaz Castrillón, Francisco Javier
Aguilar Jiménez, Wbeimar
Taborda Vanegas, Natalia Andrea
Hernández López, Juan Carlos
Rugeles López, María Teresa

Tipo de recurso:

Article of investigation

Fecha de publicación:

2022

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/35478

Acceso en línea:

https://hdl.handle.net/10495/35478

Palabra clave:

SARS-CoV-2
Enfermedades Transmisibles
Communicable Diseases
Anticuerpos Neutralizantes
Antibodies, Neutralizing
Informes de Casos
Case Reports
Vacuna BNT162 - Colombia
BNT162 Vaccine - Colombia

Rights

openAccess

License

http://creativecommons.org/licenses/by/2.5/co/